Clinical Trial Update: Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether canagliflozin improves ultrafiltration and reduces fibrosis in patients with end-stage renal disease on peritoneal dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease Stage 5d
• End-stage Renal Disease

Drugs mentioned

• Canagliflozin (canagliflozin)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: ESRD, CKD (Chronic Kidney Disease) Stage 5D | Phase 2 | Status: RECRUITING